Authors




Swapna Johnson, MD

Latest:

Efficacy of Ezetimibe 2.5 mg With a Novel Tablet-Splitting Strategy

This prospective randomized study suggests that ezetimibe 2.5 mg, delivered as an ezetimibe/simvastatin tablet split into 4 parts, is clinically equivalent to a 10-mg dose.


Audrey Castle, PharmD

Latest:

Outpatient Cancer Center Cost Evaluation of Extended Beyond-Use Dating with a Closed-System Transfer Device

There is a constant balancing act for health care systems to provide the newest and most up-to-date care for patients while being financially responsible.


Margie E. Snyder, PharmD, MPH

Latest:

Implications of the CMMI Enhanced Medication Therapy Management Program for the Future of Community Pharmacy

In 2006, the Medicare Prescription Drug, Improvement, and Modernization Act of 2003 was implemented, marking the launch of medication therapy management services under Medicare Part D.


Simone Sloan, RPh, MBA

Latest:

Can Blockchain Play a Role in Revamping Health Care?

Health care costs in the US represent nearly 20% of the GDP.


Amanda Binkley, PharmD, AAHIVP

Latest:

Hepatitis C Treatment

There are now 8 FDA approved medications for HCV treatment, all of which bypass the use of interferon.



Tom Rhoads

Latest:

Using Technology for Patient Engagement: Are We There Yet?

New tools and platforms can help pharmacists to support patients.


Kirk McKay, Managing Editor

Latest:

The 340B Drug Pricing Program: Keeping Up with Changes

Health-system pharmacists need to stay abreast of changes.


Michael A. Nameth, RPh, MBA

Latest:

Commentary: Specialty Pharmacy Helps Promote Patient Adherence

Successful outcomes with specialty pharmaceuticals depend on patient adherence—pharmacists play a vital role in educating patients prior to and during therapy.


Stephanie Gurren, PharmD Candidate

Latest:

States Continue to Expand Availability of Telehealth

Telehealth has become a viable niche in US health care because it lets patients and providers use technology to seek medical advice and diagnose and treat illnesses.


John S. Linehan

Latest:

Conflicting State Compounding Regulations Create Barriers for FDA-Registered Outsourcing Facilities

Although the federal government has taken steps to comprehensively regulate outsourcing facilities, many states have been slow to reform their pharmacy laws.


Natalie R. Jacuzzi, MPH

Latest:

Impact of Medicaid Preferred Drug List on Long-Acting Opioid Users

An opioid preferred drug list was not associated with an increase in emergency department visits or hospitalizations in a Medicaid population.


Tomoko Sugihara, MS

Latest:

Defining the Teriparatide Patient: Osteoporosis Sequence of Care and Healthcare Resources

This study provides real-world evidence of a teriparatide (TPTD) patient’s characteristics, sequence of care, and healthcare resource utilization, and compares TPTD patients with non-TPTD patients.



Gilbert N. Muma, PhD

Latest:

Persistence With Mirabegron Versus Tolterodine in Patients With Overactive Bladder

In a retrospective analysis of the Optum database, overactive bladder patients treated with mirabegron bladder patients persisted longer with treatment than patients treated with tolterodine, and had reduced resource utilization and costs.


Barbara J. Wilson-Relyea, PhD

Latest:

Cost Outcomes of Diabetes Education in a Specialized Community Pharmacy

Diabetes management offered by an employer group in a self-funded health plan over 3 years resulted in significant cost savings and improved patient outcomes.


Jenny Bingham, PharmD, BCACP

Latest:

Telepharmacy Offers Opportunity Amid Pandemic

The contributions to patient care through the incorporation of digital clinical pharmacotherapy will help legitimize the role of pharmacists in telehealth.


Daniel Merenstein, MD Professor

Latest:

The Expanding Health Benefits of Prebiotics and Probiotics

A Continuing Education program, featured in the February 2018 issue of Pharmacy Times.


Rahul Shenolikar, PhD

Latest:

COPD Medication Adherence and Persistence Among Managed Medicare Enrollees

The authors evaluated the significance of Medicare prescription plan choice on chronic obstructive pulmonary disease maintenance medication adherence and persistence using Optum Research Database information.


Brandon Dionne, PharmD, BCPS-AQ ID, BCIDP, AAHIVP

Latest:

New Antibiotics Treat Select Resistant Infections

Cefiderocol and IV fosfomycin are exciting new options, and further clinical outcomes data will help define their roles.


Hari Rayapudi

Latest:

What Makes a Good Call Center for Patient Assistance Program Success?

Effective specialty pharmacy patient assistance programs help patients access and remain adherent to high cost drugs.


Willis Chandler, SVP & President, Health Systems & Specialty Services, AmerisourceBergen

Latest:

Implementing a Health-System Specialty Pharmacy

By establishing in-house specialty pharmacies, health systems can accelerate growth while offering patients innovative therapies, an enhanced experience, and clinically coordinated care that ultimately improves outcomes.




Thanh Nguyen, PharmD

Latest:

Hypertension: Promoting Adherence When a Condition Is "Silent"

Educating patients about lifestyle changes, strict medication adherence, and home blood pressure monitoring can help them to avert complications from this often silent condition.


Rebecca Nolen, PharmD, BCPS, AAHIVP

Latest:

FDA Adds Novel Antimicrobials to Arsenal

Antimicrobial resistance continues to pose a significant health threat, necessitating new antibiotics with novel mechanisms to treat these complicated infections. However, between 2010 and 2018, newly approved antibiotics were primarily derived from previously established drug classes. This past summer, the FDA approved 2 new antibiotics.


Himayapsill Batista Quevedo, PharmD

Latest:

Pharmacists Can Help Assess New FDA-Approved IV Opioid

Oliceridine (Olinvyk) expands options for managing moderate to severe acute pain, but cost, drug-drug interactions, and other factors come into play.


Rachel Root, PharmD, MS, BCPS

Latest:

Fostering Rapid Innovation During a Time of Crisis

Promoting an environment that allows for rapid problem-solving and execution under high stress is essential to face problems that are poorly understood and yet require rapid change.